Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design
- William Farnaby, M. Koegl, +34 authors A. Ciulli
- Chemistry, Medicine
- Nature Chemical Biology
- 10 May 2019
Targeting subunits of BAF/PBAF chromatin remodeling complexes has been proposed as an approach to exploit cancer vulnerabilities. Here, we develop proteolysis targeting chimera (PROTAC) degraders of… Expand
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition
- Anja F. Hohmann, Laetitia J. Martin, +12 authors C. Vakoc
- Biology, Medicine
- Nature chemical biology
- 3 May 2016
Here we show that acute myeloid leukemia (AML) cells require the BRD9 subunit of the SWI/SNF chromatin remodeling complex to sustain MYC transcription, rapid cell proliferation, and a block in… Expand
Potent and Long-Acting Dimeric Inhibitors of Influenza Virus Neuraminidase Are Effective at a Once-Weekly Dosing Regimen
- S. Macdonald, K. Watson, +20 authors S. Tucker
- Biology, Medicine
- Antimicrobial Agents and Chemotherapy
- 1 December 2004
ABSTRACT Dimeric derivatives (compounds 7 to 9) of the influenza virus neuraminidase inhibitor zanamivir (compound 2), which have linking groups of 14 to 18 atoms in length, are approximately… Expand
Microwave‐Assisted Parallel Synthesis of Fused Heterocycles in a Novel Parallel Multimode Reactor.
- Matthias Treu, T. Karner, +4 authors A. Stadler
- Chemistry
- 31 March 2009
Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza.
- S. Macdonald, R. Cameron, +21 authors S. Tucker
- Chemistry, Medicine
- Journal of medicinal chemistry
- 16 March 2005
The synthesis, antiviral and pharmacokinetic properties of zanamivir (ZMV) dimers 8 and 13 are described. The compounds are highly potent neuraminidase (NA) inhibitors which, along with dimer 3, are… Expand
Drugging an undruggable pocket on KRAS
- D. Kessler, M. Gmachl, +39 authors D. McConnell
- Chemistry, Medicine
- Proceedings of the National Academy of Sciences
- 22 July 2019
Significance Despite decades of research, no approved drugs have been discovered for KRAS. Recently, a pocket occurring on the surface of the active and inactive form of KRAS was found, but, due to… Expand
Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.
- K. Watson, R. Cameron, +11 authors Wen-Yang Wu
- Chemistry, Medicine
- Bioorganic & medicinal chemistry letters
- 22 March 2004
A set of trimeric and tetrameric derivatives 6-11 of the influenza virus neuraminidase inhibitor zanamivir 1 have been synthesized by coupling a common monomeric zanamivir derivative 3 onto various… Expand
2-Ethoxybenzoxazole as a bioisosteric replacement of an ethyl benzoate group in a human rhinovirus (HRV) capsid binder.
- R. Brown, R. Cameron, +8 authors K. Watson
- Chemistry, Medicine
- Bioorganic & medicinal chemistry letters
- 15 April 2005
A series of pyridazinylpiperidinyl capsid-binding compounds with novel bicyclic substituents were synthesized and screened against human rhinovirus (HRV). Several 2-alkoxy- and… Expand
An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human Rhinovirus.
- S. Feil, S. Hamilton, +10 authors C. Morton
- Medicine
- ACS medicinal chemistry letters
- 16 February 2012
Respiratory infections caused by human rhinovirus are responsible for severe exacerbations of underlying clinical conditions such as asthma in addition to their economic cost in terms of lost working… Expand
Start selective and rigidify: The discovery path towards a next generation of EGFR tyrosine kinase inhibitors.
- H. Engelhardt, Dietrich Böse, +34 authors D. McConnell
- Chemistry, Medicine
- Journal of medicinal chemistry
- 5 November 2019
The epidermal growth factor receptor (EGFR), when carrying an activating mutation like del19 or L858R, acts as an oncogenic driver in a subset of lung tumors. While tumor responses to tyrosine kinase… Expand
...
1
2
3
4
5
...